Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announced that CEO John F. Crowley will speak at the Credit Suisse 29th Annual Virtual Healthcare Conference on November 9, 2020, at 8:00 a.m. ET. The event will provide insights into the company's focus on rare metabolic diseases.

Investors can access a live audio webcast of the presentation via the Amicus Therapeutics website. The company is dedicated to developing high-quality medicines for those affected by rare diseases.

CRANBURY, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020 at 8:00 a.m. ET.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When will Amicus Therapeutics present at the Credit Suisse Healthcare Conference?

Amicus Therapeutics will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on November 9, 2020, at 8:00 a.m. ET.

Who is presenting for Amicus Therapeutics at the conference?

John F. Crowley, Chairman and CEO of Amicus Therapeutics, will present at the conference.

Where can I access the Amicus Therapeutics conference presentation?

The presentation can be accessed via a live audio webcast on the investors section of the Amicus Therapeutics corporate website.

What does Amicus Therapeutics focus on?

Amicus Therapeutics is focused on discovering and developing high-quality medicines for people living with rare metabolic diseases.

What is the stock symbol for Amicus Therapeutics?

The stock symbol for Amicus Therapeutics is FOLD.